Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.